Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

2-MABB

From Wikipedia, the free encyclopedia

2-MABB
Clinical data
Other names2-(2-(Methylamino)butyl)benzofuran
ATC code
  • None
Identifiers
  • 1-(1-benzofuran-2-yl)-N-methylbutan-2-amine
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC13H17NO
Molar mass203.285 g·mol−1
3D model (JSmol)
  • CCC(CC1=CC2=CC=CC=C2O1)NC
  • InChI=1S/C13H17NO/c1-3-11(14-2)9-12-8-10-6-4-5-7-13(10)15-12/h4-8,11,14H,3,9H2,1-2H3
  • Key:YBPPNDUCEMDPJZ-UHFFFAOYSA-N

2-MABB, also known as 2-(2-(methylamino)butyl)benzofuran, is a psychoactive drug of the substituted benzofuran family.[1][2][3][4] It was encountered as a novel designer drug in Europe in 2016.[4] The drug has been made a controlled substance in Sweden, Italy, and Russia.[1][2][3]

See also

[edit]

References

[edit]
  1. 1 2 "2-MABB". AIPSIN Drugs (in Russian). Retrieved 3 February 2026.
  2. 1 2 "2-MABB". AIPSIN Drugs (in Russian).
  3. 1 2 Di Luca NM, Busardò FP, Pirani F, Varì MR (2020). "Evolution of Italian laws banning trafficking, use and abuse of psychotropic drugs". Annali dell'Istituto Superiore di Sanita. 56 (1): 76–89. doi:10.4415/ANN_20_01_12. PMID 32242539.
  4. 1 2 Annual Report on the implementation of Council Decision 2005/387/JHA. EMCDDA–Europol (Report). 2016.
[edit]